The analysis of the pharmaceutical supply with medicines used in insect allergy therapy and approaches to the development of new medicines in the form of a gel for the local treatment
DOI:
https://doi.org/10.24959/sphhcj.21.221Keywords:
local allergic reactions; insect allergy; gel dosage form; local treatmentAbstract
According to the World Allergy Organization, allergies occur in 10 % to 40 % of the world’s population. Currently, the number of such patients in Europe is about 150 million people. It is projected that in the next decade there will be more than 250 million people, 5 % of whom have a predisposition to insect allergies (IA).
Aim. To analyze the range of drugs used in the local treatment of IA and approaches to the development of new domestic drugs in the form of a gel.
Materials and methods. The scientific publications of domestic and foreign authors, data from official sites on the subject, ICD-10, materials of the State Register of Medicines of Ukraine, directory Compendium, Protocol for medical care for insect allergies, as well as methods of the system analysis, comparison, graphical, analytical and the content analysis were used.
Results. The regimen of IA treatment has been studied depending on the severity (mild, moderate, severe, anaphylactic shock), which is given in the Protocol of medical care for insect allergies in accordance with the Order of the Ministry of Health of Ukraine from 03.07.2006 No.432. It is considered that IA is treated with the subgroup “D04A A – Antihistamines for topical application”, which has only 5 drugs (including release forms); among them 80 % of medicines are foreign, 60 % are produced in the form of a gel. It is very insufficient because of the fact that there are consequences of insect bites during the local therapy of children since constant scratching of the bite sites is a threat of infection of wounds and delay their healing.
Conclusions. On the example of the pharmaceutical composition in the form of a gel, the expediency for developing new domestic drugs that are available compared to foreign ones for the local therapy in IA, and manifestations of allergic reactions to insect bites has been proven.
References
World Allergy Organization. URL: https://www.worldallergy.org/.
European Academy of Allergy and Clinical Immunology, EAACI. URL: https://www.eaaci.org/organisation/about-us.html.
Артюх А. Місце антагоністів лейкотрієнів в лікуванні алергічних захворювань. Пульмонологія, Алергологія, Риноларингологія. 2020. № 1 (50). С. 27.
The American College of Allergy, Asthma and Immunology. URL: https://college.acaai.org/about-us/.
Махарадзе Д. Ш. Инсектная аллергия и особенности ее терапии. Медицина неотложных состояний. 2007. № 4 (11). С. 110–112.
Diagnostic procedures and practices in drug allergy/hypersensitivity: a survey of 13 Asian countries / Min-Moon Tang et al. Asia Pacific Allergy. 2020. Vol. 10 (40). P. e36. DOI: https://apallergy.org/DOIx.php?id=10.5415/apallergy.2020.10.e36.
Порівняльний аналіз асортименту м’яких лікарських засобів на фармацевтичному ринку України / Т. А. Грошовий та ін. Фармацевтичний часопис. 2020. № 4. С. 40–46. DOI: https://doi.org/10.11603/2312-0967.2020.4.11647.
Vons B. V., Chubka M. B., Groshovyi T. A. Market analysis of semisolid dosage forms registered in Ukraine and research of excipients included to their formulas. Фармацевтичний часопис. 2015. № 1. С. 55–61. DOI: https://doi.org/10.11603/2312-0967.2015.1.3766.
Development of mosquito repellant gel formulations from various natural volatile oils: comparative study with the marketed formulation odomos ® / R. S. Shivhare et al. Journal of Drug Delivery and Therapeutics. 2018. № 8 (6). P. 106–110. DOI: https://doi.org/10.22270/jddt.v8i6.2031.
Гладух Є. В., Сеги А. М., Ніколайчук Н. О. Реологічні дослідження основи гелю з густим екстрактом лопуха. Соціальна фармація в охороні здоров’я. 2017. Т. 3, № 3. С. 21–26. DOI: https://doi.org/10.24959/sphhcj.17.92.
Протокол надання медичної допомоги при інсектній алергії. Про затвердження протоколів надання медичної допомоги за спеціальністю «Алергологія»: Наказ МОЗ України від 03.07.2006 р. № 432. URL: https://zakononline.com.ua/documents/show/53806___53806.
МКБ 10 − Международная классификация болезней 10-го пересмотра. URL: https://mkb-10.com/index.php?pid=11001.
Компендиум – лекарственные препараты. URL: http://compendium.com.ua/.
Лекарства. Likarinfo – портал о здоровье. URL: https://www.likar.info/lekarstva/
Фармацевтична композиція у формі гелю для лікування алергічних реакцій шкіри на подразники : пат. 143211 Україна. № u 2020 02439 ; заявл. 16.04.2020 ; опубл. 10.07.2020, Бюл. № 13. URL: https://iprop-ua.com/inv/pdf/l8lnp29c-pub-description.pdf.
Державний реєстр лікарських засобів. URL: http://www.drlz.com.ua/.
Інструкція для медичного застосування лікарського засобу Феністил гель (Fenistil Gel). URL: https://bit.ly/3uZmGns.
Інструкція для медичного застосування лікарського засобу Синафлан. URL: https://bit.ly/3hzvRan.
Rheological, mechanical and bioadhesive behavior of hydrogels to optimize skin delivery system / F. C. Carvalho et al. Drug Development and Industrial Pharmacy. 2013. Vol. 39, Iss. 11. P. 1750–1757. DOI: https://doi.org/10.3109/03639045.2012.734510.
Інструкція для медичного застосування лікарського засобу Бепантен® (Bepanthen®). URL: https://bit.ly/3wg1vh3.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
